PubRank

M McMahon

Author PubWeight™ 152.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984 8.32
2 Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994 6.07
3 Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998 5.14
4 Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997 4.36
5 Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 1998 3.23
6 Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 1993 3.13
7 Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001 2.78
8 Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 2000 2.62
9 Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 2001 2.57
10 Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 2001 2.56
11 Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 1991 2.46
12 The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 2000 2.40
13 Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 2000 2.30
14 Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997 1.88
15 Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 1995 1.87
16 Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev 1995 1.79
17 Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol 1997 1.69
18 Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J 1985 1.59
19 Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol 1999 1.58
20 A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. Arch Intern Med 2000 1.58
21 Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2012 1.57
22 Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr 1997 1.57
23 Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Leukemia 2003 1.56
24 The challenge of patients' unmet palliative care needs in the final stages of chronic illness. Palliat Med 2007 1.54
25 Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. Mol Cell Biol 2000 1.47
26 Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol 1996 1.47
27 The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 1998 1.45
28 Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem 1994 1.42
29 Diagnostic utility of tomographic myocardial perfusion imaging with technetium 99m furifosmin (Q12) compared with thallium 201: results of a phase III multicenter trial. J Nucl Cardiol 1996 1.40
30 The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol 1999 1.39
31 Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ 2000 1.38
32 Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J Exp Med 1995 1.36
33 Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells. J Virol 1986 1.31
34 Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 1991 1.30
35 A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells. BMC Immunol 2001 1.29
36 Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol 2001 1.19
37 Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src. Mol Cell Biol 1999 1.18
38 Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Oncogene 2006 1.17
39 Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 1998 1.17
40 Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1. Mol Cell Biol 1994 1.16
41 Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J Biol Chem 1996 1.16
42 The health and welfare needs of female and transgender street sex workers in New South Wales. Aust N Z J Public Health 2001 1.15
43 Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol Cell Biol 1998 1.12
44 Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol Cell Biol 1996 1.12
45 Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care 1999 1.12
46 Divergence and reticulation among montane populations of a jumping spider (Habronattus pugillis Griswold). Syst Biol 2000 1.09
47 Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J Biol Chem 1997 1.08
48 Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin Cancer Res 2001 1.06
49 Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 1997 1.05
50 Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 1990 1.05
51 Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia 2008 1.05
52 Laparoscopy: the preferred method of cholecystectomy in the morbidly obese. Surgery 1992 1.04
53 Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J Cell Biochem 1999 1.03
54 Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation. Cancer Res 1995 1.02
55 Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993 1.02
56 Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells. J Immunol 1999 1.01
57 Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus 2010 0.99
58 Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J 1998 0.98
59 A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells. Oncogene 2000 0.98
60 Effects of lead on behavior, growth, and survival of hatchling slider turtles. J Toxicol Environ Health A 1998 0.95
61 A multicase family study of rheumatoid arthritis in south west Ireland. Dis Markers 1986 0.94
62 Identification of a novel germline MET mutation in dogs. Anim Genet 2006 0.93
63 Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J Biol Chem 1997 0.93
64 Resources and estuarine health: perceptions of elected officials and recreational fishers. J Toxicol Environ Health A 1999 0.93
65 Examination of the role of MAP kinase in the response of macrophages to lipopolysaccharide. Prog Clin Biol Res 1995 0.93
66 Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Chem Res Toxicol 2001 0.92
67 Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial. J Am Diet Assoc 1999 0.91
68 Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet. Am J Clin Nutr 1996 0.90
69 Nutritional management of cardiovascular risk factors. A randomized clinical trial. Arch Intern Med 1997 0.90
70 Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. J Biol Chem 2001 0.89
71 Behavioral treatment of dizziness secondary to benign positional vertigo following head trauma. Arch Phys Med Rehabil 1991 0.89
72 Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells. Leukemia 2000 0.87
73 Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Blood 1995 0.87
74 Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 2000 0.86
75 Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus 2008 0.86
76 Hyperthermia and the heat-shock proteins of HeLa cells. Br J Cancer 1982 0.86
77 Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia 2003 0.86
78 Quinidine-induced lupus erythematosus. Ann Intern Med 1984 0.85
79 Failure of alkylated HEp.2 cells to replicate newly synthesized DNA. Mutat Res 1971 0.85
80 Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1998 0.85
81 Factors affecting blood pressure responses to diet: the Vanguard study. Am J Hypertens 2000 0.85
82 Expectations and preferences regarding confidentiality in the psychologist-client relationship. Aust Psychol 1995 0.84
83 Active mobilisation following single cross grasp four-strand flexor tenorrhaphy (Adelaide repair). J Hand Surg Eur Vol 2011 0.83
84 Uveal melanoma presenting after cataract extraction with intraocular lens implantation. Ophthalmology 1985 0.83
85 Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clin Nutr 1999 0.83
86 Exercise and hypertension. Med Clin North Am 1985 0.83
87 Raf revealed in life-or-death decisions. Nat Genet 1997 0.81
88 Neurofibroma of the infratemporal fossa: case report and technical note. Neurosurgery 1982 0.81
89 Role of the Raf/mitogen-activated protein kinase pathway in p21ras desensitization. J Biol Chem 1996 0.81
90 Effects of preplasma scale length and laser intensity on the divergence of laser-generated hot electrons. Phys Rev Lett 2013 0.81
91 Adaptation to form distortion of a familiar shape. Percept Psychophys 1991 0.80
92 Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER. Methods Mol Biol 1997 0.80
93 Personal adjustments and regimen compliance 1 year after myocardial infarction. Heart Lung 1989 0.80
94 Proto-oncogenes and plasticity in cell signaling. Cold Spring Harb Symp Quant Biol 1994 0.80
95 Influence of a nursing intervention on regimen adherence and societal adjustments postmyocardial infarction. Nurs Res 1988 0.79
96 Exercise training improves activity in adolescents with congenital heart disease. Heart 2013 0.79
97 Regimen compliance two years after myocardial infarction. Nurs Res 1991 0.79
98 Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia 2001 0.79
99 A conditionally active form of STAT6 can mimic certain effects of IL-4. J Immunol 1998 0.79
100 Secondary pancreatic infections: are they distinct clinical entities? Surgery 1992 0.78
101 Phenytoin toxicity in a critically ill, hypoalbuminemic patient with normal serum drug concentrations. Crit Care Med 1988 0.78
102 The incidence, cause and treatment of obesity in Leicester schoolchildren. Practitioner 1971 0.78
103 Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension. Am J Hypertens 1998 0.78
104 Marital functioning after cardiac surgery. Heart Lung 1990 0.77
105 Exposure of South Carolinians to commercial meats and fish within their meat and fish diet. Sci Total Environ 2002 0.77
106 Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells. Leukemia 2000 0.77
107 Characterization, expression and function of c-Met in canine spontaneous cancers. Vet Comp Oncol 2005 0.77
108 A new anorexigen assay: stress-induced hyperphagia in rats. Pharmacol Biochem Behav 1977 0.77
109 Perceptual indicators of environmental health, future land use, and stewardship. Environ Monit Assess 2003 0.77
110 Resolution of pancreatic ascites with octreotide. Arch Dis Child 1993 0.76
111 Thiamine status, vitamin supplements and postoperative confusion. Age Ageing 1988 0.75
112 The balance of care. Stud Health Technol Inform 1998 0.75
113 Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells. Exp Hematol 1993 0.75
114 Peritoneal dialysis for acute renal failure: overfeeding resulting from dextrose absorbed during dialysis. Crit Care Med 1990 0.75
115 Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers. Br J Clin Pharmacol 1989 0.75
116 Indicators of medical regimen adherence for myocardial infarction patients. Nurs Res 1985 0.75
117 Apnea in infantile botulism. J Pediatr 1994 0.75
118 Highlights of the first 100 years. Public Health Rep 1966 0.75
119 Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. J Reprod Med 1996 0.75
120 Preserving the freedom. J Emerg Nurs 1987 0.75
121 Non-specialist paediatric surgery--where should it be performed? Ir Med J 2000 0.75
122 Restraint strategies: reducing restraints in Oregon's long-term care facilities. J Gerontol Nurs 1992 0.75
123 Radiographic performance of two different total hip cemented arthroplasties. A survivorship analysis. Orthop Clin North Am 1988 0.75
124 Role of the oncogenic Raf-1 in orchestration of discrete nuclear factor-kappaB-activating pathways. Mol Cell Biol Res Commun 2001 0.75
125 Synthesis of a highly substituted N(6)-linked immobilized NAD(+) derivative using a rapid solid-phase modular approach: suitability for use with the kinetic locking-on tactic for bioaffinity purification of NAD(+)-dependent dehydrogenases. Protein Expr Purif 2000 0.75
126 The kinetic locking-on strategy for bioaffinity purification: further studies with bovine liver glutamate dehydrogenase. Protein Expr Purif 1999 0.75
127 Stressors and stress management--1 month after myocardial infarction. Rehabil Nurs 1990 0.75
128 Development of a health attitude scale. Nurs Res 1982 0.75
129 Challenges and goals. J Emerg Nurs 1987 0.75
130 A "stripping" ligand tactic for use with the kinetic locking-on strategy: its use in the resolution and bioaffinity chromatographic purification of NAD(+)-dependent dehydrogenases. Protein Expr Purif 1999 0.75
131 Effect of accessible immobilized NAD(+) concentration on the bioaffinity chromatographic behavior of NAD(+)-dependent dehydrogenases using the kinetic locking-on strategy. Protein Expr Purif 1999 0.75
132 Hour of birth. N Y State J Med 1967 0.75
133 Health beliefs of and adherence to the medical regimen by patients with ischemic heart disease. Heart Lung 1982 0.75
134 Spontaneous perforation of the cervical oesophagus. Ir Med J 1985 0.75
135 DNA synthesis, repair and chromosome breaks in eucaryotic cells. Johns Hopkins Med J 1972 0.75
136 Non-invasive, optical measurement of absolute blood volume in hemodialysis patients. Kidney Int 1996 0.75
137 Foam elastomer dressing: a liquid alternative to gauze. Nurs Mirror 1979 0.75
138 The health of teenagers: a focused ethnographic study. Public Health Nurs 1987 0.75
139 Fetal meconium peritonitis: the "vanishing hydrocele" sign. Arch Dis Child Fetal Neonatal Ed 2003 0.75
140 Time dependence of fast electron beam divergence in ultraintense laser-plasma interactions. Phys Rev E Stat Nonlin Soft Matter Phys 2012 0.75
141 Administration of blood products. Int J Trauma Nurs 2000 0.75
142 [Development of a health attitude scale]. Kango Kenkyu 1983 0.75
143 Life situations, health beliefs, and medical regimen adherence of patients with myocardial infarction. Heart Lung 1986 0.75
144 Family health and psychosocial responses to cardiovascular disease. Health Values 1984 0.75
145 Behavioral cues in the dying process and nursing implications. J Gerontol Nurs 1980 0.75
146 A case of Resistance to Thyroid Hormone without mutation in the thyroid hormone receptor beta. Ir J Med Sci 2006 0.75
147 Strategies to promote valid and reliable nursing interventions in research. West J Nurs Res 1989 0.75
148 Induction of human mRNAs by interferon. Philos Trans R Soc Lond B Biol Sci 1984 0.75
149 Fairmount. Am Herit 1979 0.75
150 A proximal CCD imaging system for high-throughput detection of microarray-based assays. IEEE Eng Med Biol Mag 1999 0.75
151 Smoking in hospitalised patients. Addict Behav 1991 0.75
152 Health attitudes and intentions: predictions of treatment for myocardial patients. Appl Nurs Res 1988 0.75
153 A content analysis of life adjustments post infarction. West J Nurs Res 1989 0.75
154 Loving the unlovable. J Emerg Nurs 1987 0.75
155 Medico-legal knowledge of general practitioners: disjunctions, errors and uncertainties. J Law Med 2001 0.75
156 A profile of the attitudes and regimen adherence of ischemic heart disease patients. Focus Crit Care 1983 0.75
157 A kinetic locking-on strategy for bioaffinity purification: further studies with alcohol dehydrogenase. Protein Expr Purif 1999 0.75
158 Makeshift technology: water and politics in 19th-century Philadelphia. Environ Rev 1988 0.75
159 The importance of low-lying axillary sentinel nodes in breast cancer patients. Clin Radiol 2011 0.75